Novel Psychedelic Shows Rapid, Durable Benefit in Postpartum Depression

Dr. Veras was recently featured in Medscape Medical News as an expert in reproductive psychiatry, commenting on promising new research examining luvesilocin, a novel psychedelic treatment for postpartum depression. Dr. Veras discussed the significance of this emerging approach, including its rapid improvement in depressive symptoms, while emphasizing the need for larger studies to better understand its effectiveness and safety.

Read the full Medscape article here.

Next
Next

Self-Blame and Panic Has Set in Among Our Pregnant Patients